Effects of chronic hyperglycaemia on incident stroke in Hong Kong Chinese patients with type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 3, 2007, Pages 220-226

  Yang, Xilin ^a   Kong, Alice P S ^a   So, Wing Yee ^a   Ma, Ronald C W ^a   Ho, Chung Shun ^a   Lam, Christopher W K ^a   Chow, Chun Chung ^a   Cockram, Clive S ^a   Tong, Peter C Y ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Case control study; Chinese; Hong Kong; Hyperglycaemia; Stroke; Type 2 diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CEREBROVASCULAR ACCIDENT; CHINESE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HONG KONG; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGED; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HONG KONG; HUMANS; HYPERGLYCEMIA; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33947312838     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.675     Document Type: Article

References (46)

1. Wu Z, Yao C, Zhao D, et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation 2001; 103: 462-468.
2. Shi FL, Hart RG, Sherman DG, et al. Stroke in the people's Republic of China. Stroke 1989; 20: 1581-1585.
3. Huang CY, Chan FL, Yu YL, et al. Cerebrovascular disease in Hong Kong Chinese. Stroke 1990; 21: 230-235.
4. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
5. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
6. Pan XR, Yang WY, Li GW, et al., National Diabetes Prevention and Control Cooperative Group. Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 1997; 20: 1664-1669.
7. Manson J, Colditz G, Stampfer M, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-1147.
8. Almdal T, Scharling H, Jensen JS, et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422-1426.
9. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
11. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
12. Huang ES, Meigs JB, Singer DE. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 2001; 111: 633-642.
13. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421-431.
14. Genuth S, Eastman R, Kahn R, et al. Implications of the United kingdom prospective diabetes study. Diabetes Care 2003; 26(Suppl. 1): S28-S32.
15. Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 2004; 27: 216-222.
16. Piwernetz K, Home P, Snorgaard O, et al. The DIABCARE monitoring group of the St. Vincent Declaration steering committee: monitoring the targets of the St. Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. Diabet Med 1993; 10: 371-377.
17. Health and Medical Development Advisory Committee (Hong Kong). Landscape on Health Care Services in Hong Kong. Available at: http://www.hwfb.gov.hk/hmdac/english/dis¶pers /dis¶pers⇋cshk.html 2005; Accessed on 17 Nov 2005.
18. Takeya Y, Popper JS, Shimizu Y, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke 1984; 15: 15-23.
19. He J, Klag MJ, Wu Z, et al. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26: 2228-2232.
20. Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke 1995; 26: 25-29.
21. Fang XH, Longstreth WT Jr, Li SC, et al. Longitudinal study of blood pressure and stroke in over 37,000 People in China. Cerebrovasc Dis 2001; 11: 225-229.
22. Zhang XF, Attia J, D'Este C, et al. Prevalence and magnitude of classical risk factors for stroke in a cohort of 5092 Chinese steelworkers over 13.5 years of follow-up. Stroke 2004; 35: 1052-1056.
23. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
24. Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.
25. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1423.
26. So WY, Ozaki R, Chan NN, et al. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension 2004; 44: 294-299.
27. Levey AS, Greene T, Kusek JW, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.
28. Harrell F. Regression Modelling Strategies with applications to Linear Models, Logistic Regression, and Survival Analysis Springer-Verlag New York: New York, 2001.
29. Kupper LL, Karon JM, Kleinbaum DG, et al. Matching in epidemiologic studies: validity and efficiency considerations. Biometrics 1981; 37: 271-291.
30. Karon JM, Kupper LL. In defense of matching. Am J Epidemiol 1982; 116: 852-866.
31. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-679.
32. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation 1998; 98: 1365-1371.
33. Iribarren C, Jacobs DR, Sadler M, et al. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 1996; 27: 1993-1998.
34. Bowman TS, Sesso HD, Ma J, et al. Cholesterol and the risk of ischemic stroke. Stroke 2003; 34: 2930-2934.
35. Denti L, Cecchetti A, Annoni V, et al. The role of lipid profile in determining the risk of ischemic stroke in the elderly: a case-control study. Arch Gerontol Geriatr 2003; 37: 51-62.
36. Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
37. Liu L, Wang JG, Gong L, et al., Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823-1829.
38. Wang JG, Staessen JA, Gong L, et al., Systolic Hypertension in China (Syst-China) Collaborative Group. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 2000; 160: 211-220.
39. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy. Diabetes 1975; 24(Suppl. 1): 65-184.
40. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
41. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
42. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
43. Moss SE, Klein R, Klein BE, et al. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-2479.
44. Lehto S, Ronnemaa T, Pyorala K, et al. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996; 27: 63-68.
45. Sherman DG, Kim SG, Boop BS, et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation follow-up investigation of Sinus Rhythm management (AFFIRM) study. Arch Intern Med 2005; 165: 1185-1191.
46. Woo J, Lau EM. Risk factors predisposing to stroke in an elderly Chinese population-a longitudinal study. Neuroepidemiology 1990; 9: 131-134.